# PROJECT_ROADMAP

---

# DOCUMENT METADATA

Document ID:
DOC-FND-003

Version:
1.9

Status:
LOCKED

Authority:
FOUNDATION

Owner:
Project Coordinator

Strategist:
ChatGPT

Implementation:
Claude

Depends On:
DOCUMENT_ARCHITECTURE.md
CORE_WORKING_RULES.md
PROJECT_FOUNDATION.md
MISSION_AND_SCOPE.md

Required By:
PROJECT_STATUS.md
All Architecture Documents

Last Updated:
2026-08-14

---

# 1. PURPOSE

This document defines the governed development roadmap of the project.

Unlike a traditional software roadmap, this roadmap is organized around governance milestones.

Each phase is completed only after its deliverables, documentation, and approval criteria have been satisfied.

---

# 2. ROADMAP PHILOSOPHY

The project follows a Governed Milestone model.

A phase is considered complete only when:

- planned deliverables are completed;
- corresponding Stable Documents are approved and locked;
- completion criteria are satisfied;
- downstream phases are unblocked.

Progress is measured by governance completion rather than coding progress.

The roadmap may be refined through minor amendments when governed architectural decisions significantly improve project organization while preserving the overall project direction.

---

# 3. PROJECT ROADMAP

## Phase 0 — Foundation

### Objective

Establish the project's identity, governance, documentation system, and working methodology.

### Deliverables

- DOCUMENT_ARCHITECTURE.md
- CORE_WORKING_RULES.md
- PROJECT_FOUNDATION.md
- MISSION_AND_SCOPE.md
- PROJECT_ROADMAP.md
- PROJECT_STATUS.md
- NOVELTY.md

### Completion Criteria

- Foundation Stable Documents approved.
- Documentation governance finalized.
- Project identity finalized.

---

## Phase 1 — System Architecture

### Objective

Design the complete architecture of the Safe Medical AI System.

### Expected Deliverables

- SYSTEM_ARCHITECTURE.md
- CLINICAL_NAVIGATION_ENGINE.md
- MEDICAL_GOVERNANCE.md
- SAFETY_FRAMEWORK.md
- RAG_ARCHITECTURE.md
- KNOWLEDGE_BASE.md
- PROMPTING_STRATEGY.md

### Completion Criteria

- Overall architecture approved.
- Component interactions defined.
- Safety architecture established.
- Knowledge architecture completed.
- Prompting strategy finalized.
- Architecture governance approved.

---

## Phase 2 — Clinical Knowledge Curation

### Objective

Build and validate the complete governance architecture required for clinical knowledge population, including clinical knowledge architecture, knowledge governance, runtime governance, operational governance, executive governance, organizational governance, regulatory readiness, documentation governance, and long-term strategic planning.
The phase concludes with a governed architecture ready for large-scale knowledge population.

### Deliverable Structure

Clinical Knowledge Architecture
KNOWLEDGE_INGESTION_WORKFLOW.md
KNOWLEDGE_OBJECT_SPECIFICATION.md
KNOWLEDGE_PASSPORT.md
CLINICAL_KNOWLEDGE_DOMAINS.md
KNOWLEDGE_RELATIONSHIP_MODEL.md

Knowledge Governance
KNOWLEDGE_SOURCE_REGISTRY.md
KNOWLEDGE_SOURCE_APPROVAL_POLICY.md
KNOWLEDGE_UPDATE_POLICY.md
RETRIEVAL_POLICY.md

Runtime Pipeline
EVIDENCE_PACKAGE_SPECIFICATION.md
RESPONSE_GENERATION_ARCHITECTURE.md
OUTPUT_VALIDATION_FRAMEWORK.md
DELIVERY_POLICY.md

Operational Governance
SYSTEM_EVALUATION_FRAMEWORK.md
MONITORING_FRAMEWORK.md
OBSERVABILITY_FRAMEWORK.md
INCIDENT_MANAGEMENT_POLICY.md
RELEASE_POLICY.md
CONTINUOUS_IMPROVEMENT_FRAMEWORK.md
QUALITY_MANAGEMENT_FRAMEWORK.md

Executive Governance
GOVERNANCE_DASHBOARD.md
GOVERNANCE_METRICS_FRAMEWORK.md
EXECUTIVE_REPORTING.md

Organizational Governance
AUDIT_FRAMEWORK.md
GOVERNANCE_MATURITY_MODEL.md
ORGANIZATIONAL_GOVERNANCE.md
RISK_MANAGEMENT_FRAMEWORK.md

Regulatory Readiness
REGULATORY_READINESS_FRAMEWORK.md

Documentation Governance
DOCUMENTATION_GOVERNANCE_FRAMEWORK.md

Strategic Planning
LONG_TERM_ROADMAP.md

### Completion Criteria

- Governance architecture completed.
- Stable Documents approved and locked.
- Documentation governance completed.
- Architecture validation passed.
- Phase Exit Review passed.
- Governance Authority approved Phase closure.
---

## Phase 3 — Knowledge Population & Clinical Content Development

### Objective
Populate, curate, validate, and maintain clinically governed knowledge assets that power the approved Medical AI architecture.

### Expected Deliverables

CLINICAL_KNOWLEDGE_POPULATION_STRATEGY.md

Knowledge Population Framework

- CLINICAL_KNOWLEDGE_OBJECT_TEMPLATE.md
- KNOWLEDGE_PASSPORT_POPULATION_GUIDE.md
- EVIDENCE_PACKAGE_POPULATION_GUIDE.md
- KNOWLEDGE_POPULATION_EXECUTION_FRAMEWORK.md
- CLINICAL_KNOWLEDGE_REPOSITORY_STRUCTURE.md
- KNOWLEDGE_POPULATION_QUALITY_FRAMEWORK.md
- KNOWLEDGE_POPULATION_PRIORITY_FRAMEWORK.md

Clinical Knowledge Assets

- Population Packages
- Clinical Knowledge Objects
- Knowledge Passports
- Evidence Packages
- Knowledge Registry
- Clinical Validation Records

### Completion Criteria

Phase 3 shall be completed when:

- Knowledge Population Framework is completed.
- Population Wave 1 has been successfully executed.
- Initial Population Packages have passed governance validation.
- Initial retrieval-ready Clinical Knowledge Repository has been established.
- Knowledge quality validation has passed.
- Population workflow has been validated for scalable expansion.

---

## Phase 4 — Repository & Integration Verification

### Objective

Verify that the governed Clinical Knowledge Repository and Population Package
assets are correctly integrated, addressable, traceable, and ready for
downstream retrieval and future implementation.

Phase 4 is not a new clinical knowledge production phase.

The central objective is to verify:

Population Package
→ Registry
→ Exact Repository Path
→ Four Gold Artifacts
→ Governance Metadata
→ Integration Evidence
→ Retrieval Readiness

### Expected Deliverables

- Population Package Integration Verification Framework
- Registry / Manifest Integration Verification
- Repository Resolution Verification
- Governance Metadata Verification
- Immutable Repository Integration Evidence
- Phase 4 Integration Verification Record

### Completion Criteria

Phase 4 shall be completed when:

- all governed Population Packages have been reconciled against their exact
  repository paths;
- canonical Gold artifacts are resolvable;
- registry and repository relationships are verified;
- lifecycle status and integration verification status are explicitly
  distinguished;
- integration evidence is traceable to an immutable repository state;
- downstream retrieval readiness requirements are verified;
- Phase 4 verification evidence has been reviewed and approved.

### Phase 4 Closure Result

Status:
CLOSED

Verification Result:
PASS

Completed Verification Layers:

- Layer 4A — Registry Integration — PASS
- Layer 4B — Repository Resolution — PASS
- Layer 4C — Governance Metadata — PASS
- Layer 4D — Immutable Integration Evidence — PASS
- Layer 3 Aggregate Verification — PASS

Closure Evidence

Phase 4 closing commit:
70067d020420eb1792419bb7d7308da524f0031c

Post-integration archive correction:
d4c2994e390d746c37276b7d29d0ba57ebae0d53

Phase 4 is formally closed and does not require further execution unless
a specific defect or corrective action is identified.

---

## Phase 5 — Implementation

### Objective

Implement and technically validate the approved Safe Medical AI
architecture through controlled, task-bounded implementation.

Phase 5 implementation shall proceed through explicit architecture,
retrieval, runtime integration, evidence/output validation, technical
validation, and clinical/safety validation gates.

### Current Implementation State

Phase 5 is CLOSED / PASS.

Completed:

- Task #002 — Implementation Scaffolding — CLOSED / PASS
- Task #003 — Retrieval Foundation — CLOSED / PASS
- Task #004 — Filesystem Repository Source — CLOSED / PASS / REMOTE VERIFIED
- Task #005 — Runtime Evidence Package — CLOSED / PASS
- Task #006 — Runtime Integration / GenerationContext — CLOSED / PASS
- Task #007 — Generation Boundary — CLOSED / PASS
- Task #008 — Validation Boundary — CLOSED / PASS
- Task #009 — Safety Enforcement Boundary — CLOSED / PASS

Task #009 final technical acceptance:

- Dedicated tests: 47 PASS
- Full regression: 287 PASS
- Independent isolated verification: 287 PASS
- Scope verification: PASS
- Technical Acceptance: PASS
- Commit: 0f413c9
- Remote verification: PASS

Phase 5 governance canonical state:

- PHASE_5_IMPLEMENTATION_READINESS_DECISION_RECORD_v12.0.md
- Phase_5_Governance_Consolidated_Decision_Record_v12.0.md

Phase 5 Closure:

CLOSED / PASS

No Phase 5 implementation task remains open.

### Expected Activities

- Controlled retrieval implementation.
- Runtime integration.
- Runtime Evidence Package assembly.
- Evidence/output validation.
- Technical validation.
- Clinical/safety validation.
- Testing and defect/risk remediation.

Activities are executed through approved task specifications rather than
as one monolithic implementation.

### Completion Criteria

- approved implementation tasks completed;
- runtime integration verified;
- evidence/output validation verified;
- technical validation passed;
- clinical/safety validation passed;
- traceability verified;
- defects and risks dispositioned;
- Phase 5 closure evidence approved.


---

## Phase 6 — Validation

### Objective

Validate the implemented system.

### Expected Activities

- Clinical expert review.
- Technical validation.
- Safety validation.
- User testing.

### Entry Gate

Phase 6 begins with an Architecture / Scope Gate.

The gate shall define:

- validation objective;
- technical validation scope;
- clinical validation scope;
- safety validation scope;
- human-oversight / user evaluation scope;
- validation batches;
- acceptance criteria;
- evidence requirements;
- exclusions;
- dependencies;
- closure criteria.

No Phase 6 validation execution shall begin before the gate is approved
and locked.
### Completion Criteria

Phase 6 shall be completed when:

- approved validation domains have been executed against the approved
  validation scope;
- validation evidence has been captured and reviewed;
- validated, partially validated, and deferred validation domains are
  explicitly distinguished;
- technical, clinical, safety, and human-oversight validation results
  are documented according to the approved validation scope;
- defects, risks, limitations, and improvement actions are dispositioned;
- any validation domain that could not be completed because sufficient
  governed source material was unavailable is explicitly recorded as:

  MISSING — REQUIRES SOURCE / CLINICAL INPUT

- deferred validation work is explicitly documented for downstream
  refinement / re-validation;
- Phase 6 acceptance and closure are approved by the Project Coordinator.

A deferred validation domain shall not be represented as validated,
and incomplete clinical validation shall not be used to overclaim
clinical deployment readiness.

### Validation Coverage Principle

Phase 6 may proceed with execution of validatable technical, safety,
human-oversight, and system-level domains even when a specific clinical
validation domain remains incomplete because sufficient governed source
material is unavailable.

Such a limitation shall be explicitly documented and shall not be
silently substituted with invented, synthetic, or otherwise ungoverned
clinical cases.

The absence of a sufficient clinical case bank does not automatically
block all other validatable Phase 6 domains, but it prevents the project
from representing that the affected clinical domain has been fully
validated.

---

## Phase 7 — Continuous Evolution

### Objective

Continue governed improvement of the Safe Medical AI System following
Phase 6 validation, including validation refinement, knowledge
expansion, governance evolution, regulatory adaptation, organizational
learning, and portfolio / showcase packaging.

### Expected Activities

- Continuous improvement.
- Validation refinement and re-validation.
- Expansion of deferred validation domains.
- Knowledge expansion and controlled knowledge updates.
- Governance evolution.
- Regulatory adaptation.
- Organizational learning.
- Portfolio and showcase packaging.

### Expected Deliverables

- Updated knowledge assets.
- Validation refinement / re-validation records.
- Governance improvements.
- Strategic roadmap revisions.
- Portfolio / showcase package.
- Technical documentation updates.
- System architecture figures.
- Demonstration materials.
- Evaluation summary.

### Completion Criteria

- Continuous-evolution activities are governed and documented.
- Deferred validation work has been appropriately advanced, revalidated,
  or explicitly maintained as an open limitation.
- Governance and knowledge updates are traceable.
- Required portfolio / showcase materials are completed.
- Phase 7 transition / closure decisions are approved.

---

# 4. PHASE TRANSITION RULES

A phase may begin only if:

- the previous phase has been completed;
- blocking decisions have been locked;
- required Stable Documents have been approved.

Skipping governance phases is discouraged unless explicitly approved by the Project Coordinator.

Architecture phases should be considered complete only after all required architectural Stable Documents have been approved, locked, and integrated into the governed documentation system.

Knowledge curation phases shall prioritize governed clinical knowledge quality over implementation speed.


# 5. CHANGE MANAGEMENT

The roadmap is intended to remain stable.

Minor additions and organizational refinements should be incorporated through amendments.

Minor roadmap refinements are permitted when governed architectural decisions improve project organization while preserving the project's overall direction.

Major restructuring requires a Major Version update.

---

# 6. SUCCESS INDICATORS

The roadmap aims to ensure that the project progresses through:

- well-defined governance;
- reproducible documentation;
- architecture-first development;
- governed clinical knowledge curation;
- safe implementation;
- research-grade outcomes.

---

# 7. RELATED DOCUMENTS

## Upstream

- DOCUMENT_ARCHITECTURE.md
- CORE_WORKING_RULES.md
- PROJECT_FOUNDATION.md
- MISSION_AND_SCOPE.md

---

## Downstream

- PROJECT_STATUS.md
- All Architecture Documents
- Clinical Knowledge Curation Documents
- Evaluation Documents
- Development Documents

---

# 8. CURRENT PROJECT POSITION

Completed Phase 3 Population Wave

Core Gastric Cancer Population Wave

Population Registry

PP-0001 → PP-0239

Population Package Baseline

239 Population Packages
956 canonical Gold artifacts

Immutable Phase 3 Git Baseline

a838a9423fc3d14c46f8cd176bafed3b691e65c0

Phase 3 Closure

Formal closure locked under LD-P4-001.

Phase 4 Closure

Repository & Integration Verification formally CLOSED.

Phase 4 Verification Result

PASS

Completed Phase 4 Layers

- Layer 4A — Registry Integration
- Layer 4B — Repository Resolution
- Layer 4C — Governance Metadata
- Layer 4D — Immutable Integration Evidence
- Layer 3 Aggregate Verification

Phase 4 Closing Commit

70067d020420eb1792419bb7d7308da524f0031c

Post-integration Archive Correction

d4c2994e390d746c37276b7d29d0ba57ebae0d53

Current Strategic Priority

Prepare Phase 5 implementation under the approved architecture and
preserve the completed Phase 3 and Phase 4 baselines.

Current Phase

Phase 5 — Implementation

Current Status

Phase 3 — CLOSED
Phase 4 — CLOSED
Phase 5 — CLOSED / PASS

Completed Phase 5 Implementation

Task #002 → Task #009 — completed and technically accepted.

Phase 5 Final Commit

0f413c94ce3848c586fc3fd500706017c82d7533

Phase 5 Governance

Canonical governance state synchronized at v12.0.

Current Strategic Priority

Execute Phase 6 — Validation under the approved Architecture / Scope
Gate while preserving explicit limitations for validation domains that
lack sufficient governed source material.

Current Phase

Phase 6 — Validation

Current Status

Phase 3 — CLOSED
Phase 4 — CLOSED / PASS
Phase 5 — CLOSED / PASS
Phase 6 — VALIDATION / EXECUTION PREPARATION

Phase 6 Execution State

Architecture / Scope Gate — LOCKED
Decision Batches B01 → B19 — LOCKED
Execution Preparation Step 2A — PASS / LOCKED
Execution Preparation Step 2B — PASS WITH CONTROLLED SOURCE HOLD / LOCKED

Clinical Validation Limitation

MISSING — REQUIRES SOURCE / CLINICAL INPUT

This limitation applies specifically to the incomplete gastric
case-level clinical decision and safety validation coverage.

Other validatable Phase 6 domains may proceed under the approved
validation scope.

Actual Validation Execution

NOT YET STARTED

Next Controlled Milestone

Phase 6 — Validation Execution Readiness

---

# 9. AMENDMENT HISTORY

## Version 1.9

Updated following Phase 6 Execution Preparation and governance
clarification of the relationship between Phase 6 Validation and
Phase 7 Continuous Evolution.

Amendments include:

- Clarified Phase 6 completion criteria to distinguish validated,
  partially validated, and deferred validation domains.
- Established explicit handling of validation gaps recorded as
  MISSING — REQUIRES SOURCE / CLINICAL INPUT.
- Clarified that incomplete clinical validation shall not be
  represented as validated or used to overclaim clinical deployment
  readiness.
- Clarified that validatable technical, safety, human-oversight, and
  system-level domains may proceed despite an explicitly documented
  clinical-source limitation.
- Renamed Phase 7 from Portfolio Packaging to Continuous Evolution.
- Expanded Phase 7 objectives to include validation refinement,
  knowledge expansion, governance evolution, regulatory adaptation,
  organizational learning, and portfolio packaging.
- Updated the Current Project Position to reflect Phase 6 execution
  preparation.
- Recorded the deferred gastric clinical validation limitation.

No major architectural restructuring introduced.

---

## Version 1.8

Updated following formal closure of Phase 5 — Runtime Implementation and
Safety Enforcement.

Major updates include:

- Phase 5 status updated to CLOSED / PASS.
- Task #002 through Task #009 recorded as completed.
- Task #009 technical acceptance recorded.
- Dedicated Task #009 verification recorded as 47 PASS.
- Full regression recorded as 287 PASS.
- Independent isolated verification recorded as PASS.
- Phase 5 final commit recorded:
  0f413c94ce3848c586fc3fd500706017c82d7533
- Phase 5 remote verification recorded as PASS.
- Phase 5 canonical governance state recorded at v12.0.
- Phase 6 established as the next project phase.
- Phase 6 Architecture / Scope Gate established as the first controlled
  milestone.

No major architectural restructuring introduced.

---

## Version 1.6

Updated following formal closure of Phase 4.

Amendments

### Phase 4

Updated status to:

- CLOSED
- Layer 4A — PASS
- Layer 4B — PASS
- Layer 4C — PASS
- Layer 4D — PASS
- Layer 3 Aggregate Verification — PASS

Recorded Phase 4 closing commit:

70067d020420eb1792419bb7d7308da524f0031c

Recorded post-integration archive correction:

d4c2994e390d746c37276b7d29d0ba57ebae0d53

### Phase 5

Updated current project position to:

Phase 5 — Implementation — Planned

No major architectural restructuring introduced.

---

## Version 1.5

Updated following formal closure of Phase 3 and transition into
Phase 4 — Repository & Integration Verification.

Amendments

### Phase 3

Updated Phase 3 status to:

- CLOSED
- PP-0001 → PP-0239 complete
- 239 Population Packages
- 956 canonical Gold artifacts
- Immutable Git baseline recorded

### Phase 4

Updated current phase to:

- Phase 4 — Repository & Integration Verification
- Layer 4A — Registry Integration
- Layer 4B — Repository Resolution
- Layer 4C — Governance Metadata
- Layer 4D — Immutable Integration Evidence

Integrated Locked Decisions

- LD-P4-001 — Phase 3 Formal Closure
- LD-P4-002 — Phase 4 Verification Status Vocabulary

No major architectural restructuring introduced.

---
## Version 1.4

### Summary

Updated following completion and locking of the Phase 3B Knowledge Asset Organization & Coverage Mapping layer and transition into Phase 3C Clinical Knowledge Asset Population / Execution.

### Amendments

#### Phase 3

Renamed Phase 3 consistently as:

Knowledge Population & Clinical Content Development

Updated Phase 3 status to distinguish:

- Phase 3A — Knowledge Population Strategy — Completed
- Phase 3B — Knowledge Asset Organization & Coverage Mapping — Completed and Locked
- Phase 3C — Clinical Knowledge Asset Population / Execution — Active

#### Current Project Position

Updated to reflect:

- Population Registry PP-0001 → PP-0239
- Sheet 1 — Master Registry — Locked
- Sheet 2 — Topic Mapping — Locked
- Sheet 3 — PP Mapping — Locked
- Sheet 4 — Coverage Dashboard — Locked
- Core Gastric Cancer Population Wave
- Population Package as the Phase 3C production unit

#### Execution Governance

Clarified that Population Package sequencing remains under explicit Project Coordinator control.

No major architectural restructuring introduced.

---
## Version 1.3

### Summary

Updated following completion of the Knowledge Population Framework and official transition into Population Wave 1.

### Amendments

#### Phase 3

Expanded Expected Deliverables to distinguish:

- Knowledge Population Framework
- Clinical Knowledge Assets

Updated Completion Criteria to include:

- completion of the Knowledge Population Framework;
- execution of Population Wave 1;
- validation of scalable Population Package production.

#### Current Project Position

Updated to reflect:

- Knowledge Population Framework completed;
- Execution Layer started;
- Population Wave 1 initiated;
- Locked Decisions updated to LD-0425.

---
## Version 1.2

### Summary

Updated following successful completion of Phase 2.

### Amendments
Phase 2
Updated Objective.
Updated Deliverable Structure.
Updated Completion Criteria.
Phase 3
Updated Objective.
Updated Expected Deliverables.
Updated Completion Criteria.


#### Roadmap Structure
The roadmap structure remains unchanged.

---
## Version 1.1

Minor Foundation Release.

### Summary

Refined the governed project roadmap following completion of the System Architecture phase.

### Amendments

#### Roadmap Structure

- Moved KNOWLEDGE_BASE.md from Phase 2 to Phase 1.
- Moved PROMPTING_STRATEGY.md from Phase 2 to Phase 1.
- Removed GUIDELINE_POLICY.md as an independent Stable Document.
- Renamed Phase 2 from **Knowledge Architecture** to **Clinical Knowledge Curation**.

#### Phase Objectives

Updated the objective of Phase 2 to emphasize:

- clinical knowledge curation;
- knowledge governance;
- knowledge lifecycle management;
- operational knowledge workflows.

#### Phase Deliverables

Introduced a deliverable structure consisting of:

- Clinical Knowledge Assets;
- Operational Specifications;
- Knowledge Repository Assets.

#### Completion Criteria

Updated Phase 1 completion criteria to include:

- Knowledge Architecture completed;
- Prompting Strategy finalized;
- Architecture governance approved.

Updated Phase 2 completion criteria to include:

- Initial Clinical Knowledge Assets curated;
- Knowledge ingestion workflow approved;
- Knowledge governance workflow operational;
- Initial knowledge repository established.

#### Roadmap Governance

Added roadmap refinement guidance permitting minor organizational amendments while preserving overall project direction.

---
## Version 1.0

Initial release.

Established:

- Governed Milestone roadmap.
- Phase structure.
- Deliverables for each phase.
- Completion criteria.
- Phase transition rules.
- Change management strategy.

Locked Decisions incorporated:

- Governed Milestone Philosophy.
- Outcome First.
- Documentation-driven Development.
-````

---
This section shall always reflect the current execution status of the project and shall be updated through minor amendments whenever a new phase, milestone, or major project transition is completed.
